↓ Skip to main content

The efficacy of alendronate for the treatment of thalassemia-associated osteoporosis: a randomized controlled trial

Overview of attention for article published in Frontiers in endocrinology, May 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The efficacy of alendronate for the treatment of thalassemia-associated osteoporosis: a randomized controlled trial
Published in
Frontiers in endocrinology, May 2023
DOI 10.3389/fendo.2023.1178761
Pubmed ID
Authors

Pokpong Piriyakhuntorn, Adisak Tantiworawit, Mattabhorn Phimphilai, Somdet Srichairatanakool, Waralee Teeyasoontranon, Thanawat Rattanathammethee, Sasinee Hantrakool, Chatree Chai-Adisaksopha, Ekarat Rattarittamrong, Lalita Norasetthada, Kanda Fanhchaksai, Pimlak Charoenkwan

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Lecturer 2 11%
Student > Ph. D. Student 2 11%
Unspecified 1 6%
Student > Bachelor 1 6%
Other 1 6%
Other 2 11%
Unknown 9 50%
Readers by discipline Count As %
Nursing and Health Professions 3 17%
Medicine and Dentistry 3 17%
Neuroscience 1 6%
Unspecified 1 6%
Unknown 10 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 June 2023.
All research outputs
#21,243,571
of 26,083,840 outputs
Outputs from Frontiers in endocrinology
#6,970
of 13,350 outputs
Outputs of similar age
#306,241
of 408,523 outputs
Outputs of similar age from Frontiers in endocrinology
#345
of 750 outputs
Altmetric has tracked 26,083,840 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,350 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 408,523 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 750 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.